We have detected a novel splice variant of the hypoxanthine-guanine phosphoribosyl transferase (HPRT) gene in two human oocytes and four preimplantation embryos from the 4-cell to the 8-cell stage of development. The novel HPRT transcript lacks exons 4, 5 and 6 of the normal HPRT gene. The same parental origin for the two oocytes and two of the preimplantation embryos, in which the alternatively spliced transcript was detected, might suggest that the alternative splicing is influenced by genetic background. Mutations in the HPRT gene which cause alternative mRNA splicing are implicated in Lesch-Nyhan syndrome. However, the relatively high frequency of detection of this novel HPRT transcript described here (6/109 oocytes and preimplantation embryos) suggests that it is not involved in Lesch-Nyhan syndrome. It is probable that the alternative HPRT transcript is derived from the aberrant splicing of a small percentage of the total mRNA produced from normal HPRT alleles. The presence of this alternative transcript in human preimplantation embryos may complicate an reverse transcription-polymerase chain reaction-based preimplantation diagnosis of Lesch-Nyhan syndrome.
Introduction
Lesch-Nyhan syndrome, a severe neurological disorder occurring only in males, is caused by mutations in the X-linked hypoxanthine-guanine phosphoribosyl transferase gene HPRT (Lesch and Nyhan, 1964; Gibbs et al., 1989; Davidson et al., 1991) . A large proportion of mutations in the HPRT gene result in the aberrant splicing of the 1.6 kb HPRT transcript, producing single or multiple exon deletions in the transcribed mRNA (Steingrimsdottir et al., 1992) . Therefore, we have considered the possibility of a reverse transcription-polymerase chain reaction (RT-PCR)-based approach to the preimplantation diagnosis for Lesch-Nyhan syndrome.
The PCR amplification of genomic DNA sequences from a single biopsied blastomere is a common approach to the preimplantation diagnosis of genetic disease (for review see Handyside and Delhanty, 1997; Lissens and Sermon, 1997) . The sensitivity of the PCR procedures used in the preimplantation diagnosis of genetic disease is such that the two molecules of the sequence under test in a single diploid cell are detectable. However, problems may arise which could decrease the efficiency and accuracy of detection, e.g. failure of PCR amplification, contamination or preferential amplification of one of the two alleles in a heterozygote. If the number of molecules of the sequence under test were increased, the efficiency and accuracy of diagnosis could be increased. Thus, when the profile of expression for a particular gene is known throughout preimplantation development, the use of a diagnostic RT-PCR procedure may prove more reliable due to the increased abundance of cDNA molecules in comparison to just two genomic DNA molecules. In addition, single cell RT-PCR-based procedures are much cheaper than the new, highly sensitive fluorescent PCR procedures currently used for preimplantation genetic diagnosis (Lissens and Sermon, 1997) .
We have previously described an RT-PCR procedure capable of detecting HPRT cDNA in one-tenth of the cDNA derived by reverse transcription of the mRNA from a single cell (Daniels et al., 1997a,b, and unpublished data) . Our PCR protocol for the HPRT gene uses PCR primers which span eight of the nine transcribed exons of the HPRT gene and, hence, the majority of alternative splice sites. Therefore, this RT-PCR procedure would detect aberrantly spliced HPRT mRNA from a mutant allele for a large proportion of HPRT gene mutations.
During our previous studies on gene transcription in the human preimplantation embryo, we have assayed for the presence of HPRT transcripts as a positive control for the presence of the single cell sample and for the efficiency of the reverse transcription reaction (Daniels et al., 1997a,b, and unpublished data) . In a number of oocytes and preimplantation embryos from the 1-cell to the 8-cell stage of development, we have detected a novel spliced mRNA species of the HPRT gene, lacking exons 4, 5 and 6. In this paper, we describe this novel HPRT transcript and discuss the possibility of an RT-PCR-based preimplantation diagnosis for Lesch-Nyhan syndrome.
Materials and methods

Samples
Oocytes
Oocytes which had failed to be fertilized after in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) were donated by patients attending the Assisted Conception Unit, King's College Hospital. At the time of sample preparation the oocytes were staged at 20-24 h post-insemination and 60-64 h post human chorionic gonadotrophin (HCG). Oocytes were scored as unfertilized if a male pronucleus had not formed 24 h after the IVF or ICSI procedures and the oocytes did not cleave on further incubation. It should be noted therefore that all oocytes used in this study may contain a sperm genome which had failed to form a pronucleus.
Preimplantation embryos
Embryos derived by IVF or ICSI, and not used for transfer or freezing, were donated by patients attending the Assisted Conception Unit, King's College Hospital, following research covered by Human Fertilisation and Embryology Authority licence number R0063. The zona pellucida of each oocyte or embryo was removed as follows. Using finely pulled glass pipettes, oocytes and embryos were placed in drops of acid Tyrode's solution (pH 2.0-2.4, Sigma) under oil and observed under a dissection microscope until the zona pellucida had just dissolved (between 20 and 40 s). Oocytes and embryos were then washed through drops of phosphate-buffered saline or culture medium. Great care was taken to remove any contaminating sperm or cumulus cells.
Fibroblasts
Cultured fibroblasts were obtained from John Rainer (Biochemistry Unit, Institute of Child Health). Following trypsin treatment, fibroblasts were resuspended in Hai's medium (Imperial Laboratories Ltd, Hants, UK) and kept on ice. Fibroblasts were then isolated singly or in groups of two, in droplets of PBS under oil, using finely pulled glass pipettes.
Sample Preparation
Samples (0.5 µl) were added to 1.5 µl lysis buffer [0.8% Igepal (Sigma, Poole, UK), 1 U/µl RNAsin (BRL, Paisley, UK), 5 mM DTT (BRL)], centrifuged briefly at 12 000 g and overlayed with one drop of mineral oil (Sigma). Samples were then frozen in liquid nitrogen and stored at -70°C. Prior to reverse transcription, samples were held at 80°C for 5 min in order to denature the mRNA. Samples were then transferred immediately to ice before the addition of reverse transcription reagents.
Reverse transcription
The reverse transcription reagents were mixed on ice and 3 µl added to each cell lysate to produce a final volume of 5 µl, comprising: the cell lysate, 1ϫ reverse transcription buffer (BRL), 40 U superscript reverse transcriptase (BRL), 0.9 mM each deoxynucleotide (Pharmacia, UK), 5 mM DTT (BRL), 2.25 µg random hexamers (BRL) and 2 U RNAsin (Boerhinger, Lewes, UK). Negative controls, omitting the reverse transcriptase enzyme and omitting added sample, were included in all experiments. Contamination was very rare, but when it did occur the results of that experiment were discounted. Reverse transcription was carried out at 37°C for 1.5 h. Samples were then immediately returned to ice.
PCR amplification
Following reverse transcription, 1/10 (0.5 µl) of the final reaction mix was amplified using primers for HPRT cDNA (Gibbs et al., 1989) . The remaining 4.5 µl was then amplified using primers for other genes under study (see Daniels et al., 1997a,b, and unpublished data) . PCR amplification was carried out in a total volume of 25 µl comprising the cDNA, 1ϫ PCR buffer (Perkin Elmer, UK), 25 pmol each primer, 200 mM each dNTP (Pharmacia) and 1.25 U Amplitaq DNA polymerase (Perkin Elmer). The PCR cycle parameters were: two cycles of 93°C ϫ5 min; 60°C ϫ1 min; 73°C ϫ2 min followed by 30 cycles of 93°C ϫ1 min; 60°C ϫ1 min; 73°C ϫ2 min in a Techne PHC-II or GeneE thermal cycler. A second round of PCR amplification was carried out using hemi-nested primers, by diluting 1 µl of the first round reaction into 25 µl of a new reaction mix prepared as above. The sensitivity and specificity of the PCR reaction was increased by the addition of 1.25% formamide. Figure 1 shows the region of the HPRT cDNA amplified by the RT-PCR procedure showing exon/intron boundaries, PCR primer positions and primer sequences.
Gel electrophoresis
PCR product (14 µl) was mixed with 2 µl of loading buffer and electrophoresed on a 3% agarose gel containing 2 µg/ml ethidium bromide, for 60 min at 120 V. The products were visualized and photographed under short wave length UV light.
Product recovery and sequencing PCR product bands to be recovered and sequenced (to confirm identity) were electrophoresed on a 1.5% Nusieve agarose gel, cut out of the gel using a sterile scalpel blade, dissolved in Tris-EDTA by heating to 60°C for 15 min and the PCR products extracted using phenol/chloroform and precipitated using established protocols (see Sambrook et al., 1989) . The isolated cDNA product was ligated into the pTAG vector (RϩD Systems Europe Ltd, Abingdon, UK) in a 10 µl reaction mix comprising~100 ng of the cDNA product, 50 ng of the pTAG vector, 1ϫ ligation reaction buffer (Gibco BRL), 1 mM ATP and 5 U T4 DNA ligase. The ligation reaction was carried out at 15°C overnight. 5 µl of the ligated DNA were transformed into competent E.coli XL1-Blue cells. Isolation and restriction enzyme analysis of plasmid DNA followed established protocols (Sambrook et al., 1989) . Sequencing of both strands of the cDNA inserts was carried out using the dideoxy chain-termination methods (Sanger et al., 1997) employing a cycle sequencing protocol (Amersham, Little Chalfont, UK) in a Techne PHC-II thermal cycler.
Results
Detection of a novel HPRT transcript in human oocytes and preimplantation embryos
In the course of our studies on gene transcription and its regulation during human preimplantation development (Daniels et al., 1997a,b , and unpublished data), we have analysed a total of 21 oocytes and 88 preimplantation embryos, from the 1-cell to the 16-cell stage, for the presence of transcripts of the HPRT gene. Transcripts of HPRT were detected in 20 of the oocytes (95%) and 72 of the preimplantation embryos analysed (82%). The oocyte and 12 of the preimplantation embryos in which we failed to detect HPRT transcripts were of low quality and were also negative for transcripts of all other genes analysed. Hence, transcripts of HPRT are readily detected in oocytes and all stages of preimplantation embryos using the RT-PCR technique described.
In two of the oocytes and four of the preimplantation embryos in which HPRT transcripts were detected, the amplification of a smaller HPRT cDNA product was also observed. Figure 2a shows the results obtained following the analysis of HPRT transcription in a sample containing~100 cultured fibroblasts and a single 7-cell preimplantation embryo. In addition to the expected HPRT product seen in both the fibroblasts and the 7-cell embryo, a smaller, less intense product was amplified in the 7-cell embryo. In order to determine whether this smaller HPRT product was present following the first round of PCR amplification and not simply an artefact of the second round PCR reaction, 1 µl of the first round PCR reaction mix was reamplified with the first round primers (244 and 246, Figure  2b ). The presence of a PCR product of corresponding size to that obtained in the second round of amplification, suggested that this smaller PCR product may be HPRT cDNA specific. Sequencing of the first and second round PCR products showed this smaller HPRT product to be due to the amplification of a novel HPRT cDNA lacking exons 4, 5 and 6 (Figure 3 ). In addition, the first nucleotide (guanine) of the seventh exon was missing in the sequence. The alternative mRNA transcript was seen in embryos of good quality and, hence, was not an artefact of arrested-embryo ageing or lower quality embryos. The two oocytes, the 4-cell and 7-cell embryos and a further two 8-cell embryos showing this alternatively spliced HPRT mRNA species were derived from four different couples. Note that samples were made anonymous so that there was no means of identifying these parents.
Discussion
In this paper, we describe the detection of a novel splice variant of the HPRT gene in human oocytes and preimplantation embryos from the 4-cell to the 8-cell stage of development. The six oocytes and embryos were produced by four couples in all. Sequencing of the smaller PCR product following amplification of this HPRT cDNA in the 7-cell embryo revealed a lack of exons 4, 5 and 6, and a missing guanine nucleotide at the start of exon 7. The same parental origin for the two oocytes and, for the 4-cell and 7-cell preimplantation embryos in which the alternative HPRT transcript was detected, might suggest that the alternative splicing is influenced by genetic The 387 bp product corresponding to the normal HPRT mRNA transcript is detected in the fibroblast cell sample and the 7-cell preimplantation embryo. In addition, a smaller, fainter PCR product of~220 bp is seen in the 7-cell preimplantation embryo. (b) Reamplification of the first round polymerase chain reaction (PCR) product following amplification of HPRT cDNA in the 7-cell embryo with the first round PCR primers, 244 and 246, produced the expected 587 bp product derived from the normal HPRT transcript, and a smaller PCR product of~420 bp. The smaller PCR product, therefore, showed a corresponding reduction in PCR product size to the normal HPRT transcript (167 bp smaller) after the first round of PCR amplification, as that of the smaller PCR product seen in the second round of PCR amplification shown in (a). Therefore, the smaller PCR product is amplified by the outside primers and the hemi-nested HPRT-specific primers in both the first and second rounds of PCR amplification, respectively, confirming that the smaller PCR product is indeed specific to HPRT. Sequencing of the smaller product, from both first and second rounds of PCR amplification, showed that it had spliced out exons 4, 5 and 6 (Figure 3 ).
background. Due to the anonymity of the human samples used in this study, the HPRT genes in these couples cannot be investigated further. However, the frequency of detection of this alternatively spliced HPRT cDNA (6/109 oocytes and embryos) is too high to suggest an involvement in LeschNyhan syndrome (1/100 000 males affected; Wu and Melton, 1993) . The four embryos showing the smaller transcript were not sexed but it is likely that they include both females (two copies of the HPRT gene) and males (one copy of the HPRT gene). However, in both oocytes and all four embryos both normal and alternative HPRT products were detected, which Figure 3 . Alignment of polymerase chain reaction (PCR) products from the alternatively spliced hypoxanthine-guanine phosphoribosyl transferase (HPRT) cDNA to normal HPRT cDNA. The sequence of the region of the HPRT cDNA amplified with the first round PCR primers 244 and 246. The lower sequence is that of the PCR product from the normal HPRT transcript, the upper sequence is that obtained from the alternatively spliced HPRT transcript. The first base of each exon spanned by these primers is shown in bold with the exon number indicated above. The PCR primer sequences and primer names are underlined. Note that the second round primer 243 is positioned at the start of exon 7 and hence at the alternative splice junction. Initially, therefore, following sequencing of the second round alternative HPRT cDNA PCR product (data not shown), it appeared that the smaller product may be due to an artefact of the second round PCR reaction and aberrant annealing of primer 243. However, reamplification of the first round PCR products with the first round primers and sequencing of the alternative smaller PCR product showed that this was not the case, as the cDNA product lacking exons 4, 5 and 6 was initially amplified in the first round PCR reaction. It is clear from the sequence comparison that the alternatively spliced HPRT transcript is missing exons 4, 5 and 6 and missing the first nucleotide (G) of exon 7.
suggests that the alternative HPRT cDNA is not due to a mutant HPRT allele (a mutant HPRT allele in male embryos would result in only the alternative HPRT cDNA). In addition, the reduced intensity of the PCR product obtained from the alternative HPRT transcript when compared to that obtained from the normal HPRT cDNA suggests that aberrant splicing occurs in a small percentage of the total HPRT mRNA produced.
The RT-PCR procedures used in this study of HPRT 788 transcription in human preimplantation development are applicable to the preimplantation diagnosis of those cases of LeschNyhan syndrome where the genetic mutation causes a loss of HPRT mRNA or results in alternatively spliced HPRT mRNA. It would also be advisable to simultaneously sex the embryo. We have previously described techniques for the simultaneous sexing and analysis of HPRT and XIST transcription in single cells and preimplantation embryos (Daniels et al., 1997b) . The detection of an aberrantly spliced HPRT transcript, or the absence of HPRT transcripts, and male sex in a biopsied blastomere would diagnose the embryo as mutant. The absence of any aberrantly spliced HPRT transcripts in the biopsied blastomere would indicate a normal embryo which could then be transferred back to the mother. Diagnosis would have to be carried out on blastomeres biopsied from embryos at the 8-cell stage or later to avoid the possibility of detecting HPRT transcripts inherited from the oocyte cytoplasm. Comparative studies on the levels of HPRT transcripts in oocytes and the early preimplantation stages of development suggest that, beyond the 8-cell stage, transcripts of HPRT present in the embryo are due to transcription from the zygotic genome (R. Daniels et al., unpublished data) . However, use of these RT-PCR procedures in the preimplantation diagnosis of Lesch-Nyhan syndrome is complicated by the detection of the novel alternatively spliced HPRT mRNA in two of the oocytes and four of the preimplantation embryos analysed.
We have recently shown that the onset of SNRPN (small nuclear ribonucleoprotein polypeptide N) transcription during human preimplantation development occurs in the unfertilised oocyte, and proceeds through to the 2-cell, 4-cell, 8-cell and blastocyst-stage embryo (Adjaye et al., unpublished) . However, transcription of SNRPN from the 4-cell stage onwards is exclusively from the paternally inherited allele (J. Huntriss et al., unpublished data) . Previously, it has been demonstrated that the diagnosis of Prader Willi Syndrome may be carried out by RT-PCR analysis of SNRPN transcription in leukocytes (Wevrick and Francke, 1996) . The absence of SNRPN expression being associated with Prader-Willi syndrome. The imprinted transcription of SNRPN in human 4-cell preimplantation embryos suggests that a similar approach to the diagnosis of Prader-Willi syndrome may be applicable at this stage of development.
It is clear from our work that when the profile of transcription of the particular gene under study is known in preimplantation development, such as for HPRT and SNRPN, the use of an RT-PCR-based technique may lead to a more efficient preimplantation diagnosis.
